Observational studyBreast (Edinburgh, Scotland)2020

NT-proBNP as predictor factor of cardiotoxicity during trastuzumab treatment in breast cancer patients.

Isabel Blancas et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.